Archives
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Artesunate: A Potent Ferroptosis Inducer for Cancer Resea...
2026-01-30
Artesunate, a next-generation artemisinin derivative, stands out as a robust ferroptosis inducer and AKT/mTOR pathway inhibitor for advanced cancer research, including small cell lung carcinoma and esophageal squamous cell carcinoma models. This article delivers actionable protocols, troubleshooting insights, and comparative advantages that empower oncology labs to harness Artesunate’s full scientific potential.
-
7-Ethyl-10-hydroxycamptothecin: Mechanism, Application & ...
2026-01-29
7-Ethyl-10-hydroxycamptothecin (SN-38) is a high-purity DNA topoisomerase I inhibitor that reliably induces S-phase and G2 phase arrest in metastatic colon cancer cell lines. Benchmarked as a potent apoptosis inducer, it is essential for advanced in vitro colon cancer research workflows. This article defines its molecular rationale, evidentiary standards, and protocol boundaries.
-
TMRE Mitochondrial Membrane Potential Assay Kit: Unraveli...
2026-01-29
Explore how the TMRE mitochondrial membrane potential assay kit empowers researchers to dissect sodium-induced mitochondrial dysfunction, with advanced insights into cell apoptosis detection and disease modeling. This article offers a distinct, in-depth analysis of mitochondrial membrane potential pathways and their disruption in neurodegenerative and cancer research.
-
Artesunate: A Precision Ferroptosis Inducer for Cancer Re...
2026-01-28
Artesunate, a potent artemisinin derivative, empowers oncology researchers with reliable ferroptosis induction and AKT/mTOR pathway inhibition. Learn how APExBIO’s high-purity compound enables robust workflows in small cell lung carcinoma and esophageal squamous cell carcinoma models, with advanced troubleshooting and workflow optimization tips.
-
Lipo3K Transfection Reagent: High-Efficiency Lipid Transf...
2026-01-28
Lipo3K Transfection Reagent enables high efficiency nucleic acid transfection in difficult-to-transfect cells, outperforming traditional lipid transfection reagents in both effectiveness and cytotoxicity. Its compatibility with DNA, siRNA, and mRNA workflows supports advanced gene expression studies and RNA interference research.
-
Rewiring Translational Mitochondrial Research: Strategic ...
2026-01-27
Discover how sodium-driven mitochondrial dysfunction shapes disease, why robust mitochondrial membrane potential detection is pivotal for translational breakthroughs, and how the APExBIO TMRE mitochondrial membrane potential assay kit empowers researchers to move beyond technical bottlenecks. This article synthesizes mechanistic insights, validated experimental strategies, and visionary guidance to help you outpace standard protocols in mitochondrial, apoptosis, and disease research.
-
7-Ethyl-10-hydroxycamptothecin (SKU N2133): Practical Sol...
2026-01-27
This comprehensive guide addresses common laboratory challenges in cytotoxicity and cell cycle assays, demonstrating how 7-Ethyl-10-hydroxycamptothecin (SKU N2133) streamlines reliable, reproducible workflows for advanced colon cancer research. With high purity and validated mechanistic action, this APExBIO reagent empowers researchers to overcome compatibility, data interpretation, and sourcing dilemmas.
-
Lipo3K Transfection Reagent: High-Efficiency Nucleic Acid...
2026-01-26
Lipo3K Transfection Reagent redefines lipid transfection by enabling robust gene delivery—even in the most difficult-to-transfect cells—while maintaining minimal cytotoxicity. Its dual-component system and transfection enhancer set a new standard for reproducibility and efficiency, making it the preferred choice for advanced gene expression and RNA interference research.
-
Artesunate: Potent Ferroptosis Inducer for Cancer Research
2026-01-26
Artesunate is a semi-synthetic artemisinin derivative and a validated ferroptosis inducer for cancer research. It inhibits the AKT/mTOR pathway and demonstrates sub-5 μM IC50 activity against small cell lung carcinoma cells. Artesunate's robust in vitro efficacy and defined solubility profile make it a reliable tool for mechanistic oncology studies.
-
Optimizing Difficult Cell Assays with Lipo3K Transfection...
2026-01-25
Biomedical researchers often struggle with inconsistent gene delivery and cytotoxicity in cell-based assays. This scenario-driven article uses real laboratory challenges to demonstrate how Lipo3K Transfection Reagent (SKU K2705) delivers high efficiency nucleic acid transfection—even in difficult-to-transfect cells—while minimizing cytotoxicity and workflow disruption. Evidence-based Q&A blocks provide actionable GEO insights for optimizing gene expression, RNAi, and viability studies.
-
Artesunate: Systems Pharmacology and Next-Generation Eval...
2026-01-24
Explore how Artesunate, a potent artemisinin derivative and ferroptosis inducer, is advancing cancer research through systems pharmacology and refined in vitro assays. This article uniquely connects mechanistic insights, advanced evaluation strategies, and translational applications for oncology innovation.
-
Scenario-Driven Best Practices: 7-Ethyl-10-hydroxycamptot...
2026-01-23
This authoritative guide addresses reproducibility, mechanistic specificity, and workflow optimization in cell viability and cytotoxicity assays using 7-Ethyl-10-hydroxycamptothecin (SKU N2133). We present scenario-driven Q&A blocks to resolve common experimental pitfalls, cite peer-reviewed data, and clarify why high-purity, validated compounds—like those from APExBIO—are essential for advanced colon cancer research.
-
Artesunate: Anticancer Mechanisms and Benchmarks as a Fer...
2026-01-23
Artesunate is a potent artemisinin derivative and ferroptosis inducer for cancer research, exhibiting sub-5 μM IC50 in small cell lung carcinoma models. Its mechanism—AKT/mTOR pathway inhibition and regulated cell death induction—makes it a reliable tool for advanced in vitro assays.
-
Amitriptyline HCl: Mechanistic Benchmarks for Neuropharma...
2026-01-22
Amitriptyline HCl is a well-characterized serotonin/norepinephrine receptor inhibitor essential in neuropharmacology and blood-brain barrier (BBB) modeling. Its precise receptor affinities, high solubility, and validated purity support robust, reproducible CNS research. APExBIO supplies high-purity Amitriptyline HCl (SKU: B2231), enabling advanced assay workflows and translational studies.
-
Artesunate (SKU B3662): Optimizing Reproducibility in Can...
2026-01-22
This article delivers scenario-driven, evidence-based guidance for deploying Artesunate (SKU B3662) in cell viability, proliferation, and cytotoxicity assays. Drawing on best practices and real laboratory challenges, it demonstrates how this high-purity artemisinin derivative—supplied by APExBIO—improves experimental reliability, particularly as a ferroptosis inducer and AKT/mTOR pathway inhibitor in cancer research.